Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506233 · ClinicalTrials.gov registry record
Feasibility Study of Collecting Multicenter Chronic GVHD Data
A clinical trial of Graft-Versus-Host Disease, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 13
- Enrollment target
- 2
- Study locations
NCT00506233 is a study of Graft-Versus-Host Disease that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00506233, a study of Graft-Versus-Host Disease, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 2
- Study locations
Study Summary
Primary Objective: 1\. To determine the feasibility of conducting a multi-site longitudinal observational study of patients with chronic graft-versus-host disease (GVHD).
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (2)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00506233
The ClinicalTrials.gov registry entry for NCT00506233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (84% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Graft-Versus-Host Disease appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00506233 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT00506233 about?
NCT00506233 is a clinical study titled "Feasibility Study of Collecting Multicenter Chronic GVHD Data". Primary Objective: 1\. To determine the feasibility of conducting a multi-site longitudinal observational study of patients with chronic graft-versus-host disease (GVHD).
What is the current status of trial NCT00506233?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-08.
What conditions does trial NCT00506233 study?
This clinical trial studies the following conditions: Graft-Versus-Host Disease.
What interventions are being tested in trial NCT00506233?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00506233?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00506233 being conducted?
This trial has 2 study locations across Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft-Versus-Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
RECRUITING
-
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
RECRUITING · Phase 2
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RECRUITING
-
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
RECRUITING · Phase 1
-
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RECRUITING · Phase 2
-
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.